MedPath
NMPA Approval

Brigatinib Tablets

国药准字HJ20220019

March 22, 2022

Drug Information

布格替尼片

安伯瑞

片剂

30mg

化学药品

March 22, 2022

March 21, 2027

Company Information

Applicant Company

Takeda Pharma A/S

Delta Park 45, 2665 Vallensbaek Strand, Denmark

Manufacturing Company

penn pharmaceutical services ltd; takeda ireland limited

Units 23-24, Tafarnaubach Industrial Estate, Tredegar, Gwent NP22 3AA, United Kingdom;Bray Business Park, Kilruddery, Co. Wicklow, A98 CD36, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

布格替尼片 - NMPA 批准文号 | MedPath